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Arboviruses are transmitted to vertebrate hosts by biting arthropod vectors such as mosquitoes, ticks, and midges. These
viruses replicate in both arthropods and vertebrates and are thus exposed to different antiviral responses in these organ-
isms. RNA interference (RNAi) is a sequence-specific RNA degradation mechanism that has been shown to play a major
role in the antiviral response against arboviruses in mosquitoes. Culicoidesmidges are important vectors of arboviruses,
known to transmit pathogens of humans and livestock such as bluetongue virus (BTV) (Reoviridae), Oropouche virus
(Bunyaviridae), and likely the recently discovered Schmallenberg virus (Bunyaviridae). In this study, we investigated
whether Culicoides cells possess an antiviral RNAi response and whether this is effective against arboviruses, including
those with double-stranded RNA (dsRNA) genomes, such as BTV. Using reporter gene-based assays, we established the
presence of a functional RNAi response in Culicoides sonorensis-derived KC cells which is effective in inhibiting BTV in-
fection. Sequencing of small RNAs from KC and Aedes aegypti-derived Aag2 cells infected with BTV or the unrelated
Schmallenberg virus resulted in the production of virus-derived small interfering RNAs (viRNAs) of 21 nucleotides, simi-
lar to the viRNAs produced during arbovirus infections of mosquitoes. In addition, viRNA profiles strongly suggest that
the BTV dsRNA genome is accessible to a Dicer-type nuclease. Thus, we show for the first time that midge cells target arbo-
virus replication by mounting an antiviral RNAi response mainly resembling that of other insect vectors of arboviruses.
Biting arthropods such as mosquitoes, ticks, and midges cantransmit a variety of viruses (arboviruses) belonging to the
Flaviviridae, Bunyaviridae, Togaviridae, and Reoviridae families.
Arboviruses actively replicate in both their arthropod vector and
vertebrate host. At present, mosquito-borne viruses are probably
the best-studied arboviruses. Among these are viruses of particu-
lar relevance to public health, including members of the Flaviviri-
dae family, such as dengue virus (DENV),WestNile virus (WNV),
and Japanese encephalitis virus (JEV), or alphaviruses of theToga-
viridae family, such as chikungunya virus (CHIKV) (1).
Midge-borne viruses also impact on public health. Oropouche
virus (OROV) infection can result in Oropouche fever, one of the
most important arboviral diseases in America (mainly in the Am-
azon region, Panama, and Caribbean) (2, 3). Culicoides are biting
haematophagous midges belonging to the family Ceratopogoni-
dae. Importantly, 96% of the 1,400 identified species attack
mammals, including humans. Culicoides are well-known vectors
of protozoans, filarial worms, and viruses (3), and more than 50
viruses belonging to the Bunyaviridae, Reoviridae, and Rhabdo-
viridae families have been isolated from different Culicoides spe-
cies. While some of these may be accidental infections, around
45% of isolated viruses are specific toCulicoides species, including
those known to cause infections of livestock all over the world,
such as African horse sickness virus (AHSV), bluetongue virus
(BTV) (Reoviridae) (3), and the recently discovered Schmallen-
berg virus (SBV) (Bunyaviridae) (4).
As arboviruses require vectors for successful transmission be-
tween vertebrate hosts, there is evolutionary pressure on keeping
the right balance between virus replication and vector survival.
Recent research on mosquito-arbovirus interactions indicates
that innate immune responses such as RNA interference (RNAi)
are key factors in restricting arbovirus replication (5–12), as de-
tailed in recent reviews (13, 14). Similar research onmidge-trans-
mitted arboviruses has not been carried out despite the fact that
important arboviruses are transmitted by these vectors.
RNAi has been shown to be an important and possibly the
major antiviral response in mosquitoes (13, 14). RNAi consists
of different pathways that perform sequence-specific targeting
of RNA. However, the exogenous small interfering RNA
(siRNA) pathway is of particular interest given its antiviral
function, as demonstrated in different organisms, including
drosophila and mosquitoes (13–15). The mosquito exogenous
RNAi pathway is induced by virus-derived long double-
stranded RNA (dsRNA) either derived from replication inter-
mediates or secondary structures that are targeted by the RNase
III enzyme Dicer-2 (Dcr-2) and cut into virus-derived small
interfering RNAs (viRNAs) of mainly 21 nucleotides (nt) in
length, as is assumed through comparisons toDrosophila mela-
nogaster (5, 7, 11, 12, 16–20). These viRNAs are taken up by the
RNA-induced silencing complex (RISC), harboring an argo-
naute protein (Ago-2) as the catalytic compound. viRNAs are
then unwound, and one strand is kept in the RISC to be used as
a guide to find complementary viral RNA sequences. After base
pairing, the catalytic domain of Ago-2 cleaves the target (viral)
RNA, at least in the drosophila model, which silences viral
infections (13, 14, 21–23). The exogenous siRNA pathway can
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also be artificially induced by the addition/transfection of long
dsRNA or siRNA molecules, resulting in sequence-specific si-
lencing. Key proteins of the RNA silencing pathways, such as
Dcr-2 and Ago-2, have been shown to be conserved in drosoph-
ila and mosquitoes, and the effector mechanisms are likely to
be similar. Other Dicer and Ago proteins are involved in a
variety of small RNA silencing pathways, such as the mi-
croRNA pathway (13, 14, 23). A number of RNAi-competent
mosquito cell lines, such as Aag2 (derived from Aedes aegypti)
and U4.4 (derived from Aedes albopictus), as well as Dcr-2-
deficient cell lines (C6/36 and C7-10, both derived from Aedes
albopictus), have proven to be highly useful in studying mos-
quito RNAi responses (6, 10–12, 19, 24, 25). However, nothing
is known about the presence and function of RNAi pathways,
specifically the antiviral exogenous siRNA pathway, in midges
and their derived cell lines.
BTV is one of the best-studied midge-borne viruses. It has
been shown to replicate both in its arthropod vector and mam-
malian host (26, 27). BTV infection leads to persistent infec-
tion in infected adult Culicoides or midge-derived cell culture
(28–30). This is in contrast to infected mammalian cells, which
show strong cytopathic effects (30). Given the absence of stud-
ies on Culicoides RNAi pathways and antiviral mechanisms,
nothing is known about the interactions of BTV with vector
immune responses. Many Culicoides species have been identi-
fied as BTV vectors around the world, including Culicoides
imicola in Africa (31) and Southern Europe (32), Culicoides
obsoletus and Culicoides pulicaris in Central and Northern
Europe (33, 34), and Culicoides variipennis and Culicoides so-
norensis in America (35, 36). The BTV genome consists of 10
segments of dsRNA molecules (each comprising a coding and
noncoding strand) that are packaged within a nonenveloped
triple-layered icosahedral protein capsid (37–39) and direct
the expression of 7 structural proteins (VP1 to VP7) and 4
distinct nonstructural proteins (NS1, NS2, NS3/NS3a, and
NS4) (39–41). In contrast to the single-stranded RNA arbovi-
ruses with positive-sense (alphaviruses, flaviviruses) or nega-
tive-sense (bunyaviruses) RNA genomes that have been stud-
ied in mosquitoes or mosquito cell culture systems, the dsRNA
nature of the BTV genome adds a layer of complexity for the
antiviral RNAi response in insects. During the reovirus repli-
cation cycle, second-strand RNA synthesis is believed to occur
only after assembly and consequently within the newly formed
viral particles. As such, viral dsRNA is not necessarily accessible
to the RNAi machinery. In addition to BTV, we are also inves-
tigating the RNAi response against SBV, an unrelated negative-
strand RNA arbovirus. SBV is a recently emerged virus that
affects ruminants causing mild disease (reduced milk produc-
tion, pyrexia, and diarrhea) in adults and congenital malfor-
mations in stillborns or newborns (42, 43). SBV belongs to the
genus Orthobunyavirus within the Bunyaviridae family and
possesses a three-segmented negative-sense RNA genome. The
large (L) segment encodes the RNA-dependent-RNA polymer-
ase L, the medium (M) segment encodes a polyprotein that is
cleaved into two glycoproteins (Gn and Gc) and a nonstruc-
tural protein (NSm), while the small (S) segment encodes the
nucleoprotein (N) and a second nonstructural protein (NSs).
SBV is believed to be transmitted by Culicoides species to sus-
ceptible mammalian hosts (4). Again, little is known about
control of bunyavirus replication by RNAi responses of arthro-
pod vectors. Recently, LaCrosse virus (LACV)-infected dro-
sophila cells were shown to produce virus-specific 21-nt
viRNAs mapping to all three viral segments, similar to what has
been observed for other (mainly positive-strand RNA) arbovi-
ruses (6). In addition, LACV-infected Aedes albopictus C6/36
cells, known to be deficient in Dcr-2 activity, were shown to
produce virus-specific small RNAs of different sizes (6, 44).
In this study, (i) we investigated the presence of a functional
exogenous siRNA pathway in the C. sonorensis-derived KC cell
line and (ii) we assessed whether this antiviral response targets
midge-borne arboviruses with either dsRNA (BTV) or negative-
strand RNA (SBV) genomes. We identified an exogenous siRNA
pathway in KC cells that could be induced by dsRNA or viral
infection and is effective against two arboviruses with highly dif-
ferent genome structures. A comparative analysis with BTV- or
SBV-infected Aedes aegypti Aag2 cells suggests that the midge an-
tiviral RNAi response against these viruses resembles mainly that
ofmosquitoes and points to conservation of key elements control-
ling arbovirus replication by RNAi in insect vectors.
MATERIALS AND METHODS
Cells. BSR cells, a clone of BHK-21 (kindly provided by Karl K. Conzel-
mann), were cultured in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 5% fetal bovine serum (FBS). BHK-21 cells were
grown in Glasgow minimal essential medium (GMEM) supplemented
with 10% newborn calf serum and 10% tryptose phosphate broth. CPT-
Tert cells (45), immortalized sheep choroid plexus cells (kindly provided
by D. Griffiths), were grown in Iscove’s modified Dulbecco’s medium
(IMDM) supplemented with 10% FBS. Mammalian cell lines were cul-
tured at 37°C in a 5% CO2 humidified atmosphere. KC cells, obtained
from C. sonorensis larvae, were grown in Schneider’s insect medium sup-
plemented with 10% FBS (46), Aedes aegypti-derived Aag2mosquito cells
were grown in L-15 medium supplemented with 10% FBS and 10% tryp-
tose phosphate broth. Insect cells were maintained at 28°C.
Viruses and plasmids. BTV-1 was rescued by reverse genetics as pre-
viously described (41) and derived from the reference strain of BTV-1
originally isolated at the ARC-Onderstepoort Veterinary Institute. Virus
stocks were prepared by infecting BSR cells at a low multiplicity of infec-
tion (MOI; 0.001) and harvesting the supernatant at 72 h postinfection.
The virus suspension was centrifuged at 500  g for 5 min. SBV (kindly
provided by M. Beer) was initially isolated from blood of an infected cow
and passaged once in KC cells and 6 times in BHK-21 cells. The virus was
plaque purified, and stocks were produced in BHK-21 cells by infecting
cells at a low MOI (0.01) and harvesting the supernatant at 120 h postin-
fection, followed by 20 min of centrifugation at 3,500 rpm. Virus titers of
SBV and BTV-1 were established by standard plaque assays using CPT-
Tert cells (47).
Expression vectors for invertebrate cells, pIZ-Fluc and pAcIE1-Rluc,
expressing firefly (FFluc) andRenilla (RLuc) luciferases, respectively, have
been previously described (48), and the fluorescein-labeled plasmid DNA
was commercially obtained (Mirus).
Luciferase assays. Luciferase activities were determined using a dual-
luciferase assay kit (Promega) on a GloMax-Multi microplate multi-
mode reader following cell lysis in passive lysis buffer.
dsRNA production. dsRNA for the RNA silencing experiments was
produced with the RNAi Megascript kit using gel-purified PCR products
of a specific sequence (Table 1) flanked by T7 promoter sequences. Fluo-
rescein-labeled dsRNA was produced by T7 RNA polymerase transcrip-
tion (Invitrogen) on an enhanced green fluorescent protein (eGFP)-de-
rived PCR product (using pC1-eGFP fromClontech as the template) with
the fluorescein-labeled rNTP mix (Roche) by following the manufactur-
er’s protocol. The DNA template and single-stranded RNAwere removed
by DNase1 and RNase A treatment (Ambion). dsRNA was then ethanol
precipitated, dried, and resuspended in water.
Schnettler et al.
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Transfection and infection. In order to determine the transfection
efficiency, 5 105 C. sonorensis-derived KC cells were seeded per well in
24-well plates with a glass bottom prior to transfection. DNA or dsRNA
was incubated in the presence of a variety of transfection reagents (Fu-
gene,Genejammer, and Lipofectamine 2000) and added to cells according
to the manufacturer’s protocol. In the case of Fugene and Genjammer, a
ratio of 1 to 3 (micrograms of nucleic acid to transfection reagent) was
used. At 24 h posttransfection, fluorescence in cells was analyzed using a
Zeiss laser scanning microscopy (LSM) Meta microscope.
For reporter RNAi assays, 5  104 KC cells were seeded per well in
96-well plates and transfected with 250 ng pIZ-Fluc and 50 ng pAcIE1-
Rluc using Fugene. Different concentrations of dsRNA, control (eGFP-
specific) or targeting FFluc, were either cotransfected (5 ng, 1 ng, or 0.5
ng) in 50 l of Schneider’s medium, followed by the addition of 50 l
Schneider’s medium with 30% fetal calf serum (FCS) at 2 h posttransfec-
tion, or added (300 ng or 100 ng) to cells in 100 l Schneider’s medium
with 15%FCS at 24 h posttransfection. Luciferase activity was determined
at 48 h posttransfection.
Assays to test dsRNA-induced antiviral activity were performed by
seeding 1  106 KC cells per well in 24-well plates with glass bottoms.
After 24 h, either 100 ng dsRNA, control (eGFP-specific) or specific for
BTVNS1,was transfected using Lipofectamine 2000 or 500 ng dsRNAwas
added to the medium in the absence of a transfection reagent. KC cells
were infected at an MOI of 0.2 with BTV-1 24 h posttransfection. At 2 h
postinfection, the inocula were removed and cells were washed once with
PBS. Supernatant was collected from cultured cells 24 h postinfection and
centrifuged at 500  g for 5 min. Viral titers were subsequently deter-
mined by endpoint dilution analysis on BSR cells and expressed as log10
50% tissue culture infective doses (TCID50)/ml, calculated using the
method of Reed andMuench (49). Cells were then fixed in 5% formalde-
hyde for 30 min at 24 h or 48 h postinfection (as indicated) and subse-
quently used for immunofluorescence assays or lysed for Western blot
analysis.
In vitro growth kinetics of SBV. The in vitro growth kinetics of SBV
were determined in KC and Aag2 cells following infection with anMOI of
10 for 1 h. Samples were collected at 0, 8, 24, and 48 h postinfection, and
virus titer was determined by plaque assays in CPT-Tert cells. Each exper-
iment was performed in triplicate and repeated twice.
Western blotting. Protein expression in BTV-1-infected KC cells was
assessed by SDS-PAGE and Western blotting using polyclonal rabbit an-
tiserum raised against NS1 (41) and a rabbit polyclonal anti-actin anti-
body as the control (Sigma; A5060).
Detection of proteins by immunofluorescence. Formaldehyde-fixed
cells were permeabilized by incubation in 0.3% Triton-PBS for 30 min,
followed by washing with PBS, a further incubation in 0.1% SDS-PBS for
10min, and incubation in PBS. Cells were preincubated in CAS-Block for
1 h at room temperature, followed by an incubation with CAS-Block-
diluted polyclonal rabbit antiserum raised against BTV-1 NS1 (1:2,000)
(41) or SBV N (50) (1:500) for 90 min at 37°C. Cells were then washed
three times for 5 min with PBS. Following this, an anti-rabbit antibody
conjugated with Alexa 488 diluted in CAS-Block (1:3,000) was added and
incubated for 1 h at 37°C. Following a further washing step with PBS, cells
were dried and coveredwith 4=,6-diamidino-2-phenylindole (DAPI) con-
taining mounting medium (Vectashield; hard set), and fluorescence was
detected using a Zeiss LSM meta microscope.
Small RNA isolation and deep sequencing analysis. Sequencing of
small RNAs was performed by using the Illumina Solexa platform; KC
(8  106/well) and Aag2 (2.6  106/well) cells in 6-well plates were in-
fected by BTV-1 at an MOI of 0.2 or SBV at an MOI of 10. At 24 h
postinfection (KC cells) or 48 h postinfection (Aag2 cells), total RNA was
isolated using 1 ml TRIzol (Invitrogen) per well. Glycogen was added
prior to isopropanol addition to enhance recovery of small RNA from
samples. Total RNA was then loaded on a 15% denaturing urea acryl-
amide gel, and RNAmolecules of 18 to 30 nt in size were purified from the
gel, linked to adapters, reverse transcribed, and sequenced by ARK-
Genomics (The Roslin Institute, University of Edinburgh) on the Illu-
mina Solexa platform (HiSeq 2000). Illumina adapters and sequencing
primers were removed using cutadapt (51), and the trimmed sequences
were aligned to the reference genome using Novoalign. Graphs and re-
ports were produced in R (52) using the viRome package (http://www.ark
-genomics.org/services-bioinformatics/virome). The complement-dis-
tance plots were calculated as follows: the distance between the 5= end of
reads of 24 to 30 bp thatmap on complementary strandswas counted, and
the sumof counts was plotted against the distance. For the sequence logos,
counts of each base at each position were used to create a position-weight
matrix, and the subsequent sequence logo was plotted using the seqLogo
(53) package from Bioconductor (54). Small RNAs were mapped to SBV
(GenBank accession numbers JX853179 to JX853181) or BTV-1 (Gen-
Bank accession numbers JX680457 to JX680466).
Nucleotide sequence accession number. Small RNA sequences (of
data shown and repeats) were submitted to the European Nucleotide
Archive (accession number ERP001936).
RESULTS
An active RNAi pathway is present in the KCmidge cell line.An
RNAi response can be induced in arthropod cells by sequence-
specific dsRNA either by transfection, or in case of drosophila
cells, by addition to the cell culture medium (55). We designed a
luciferase-based reporter assay in order to investigate if C. sono-
rensis-derived KC cells can induce a dsRNA-mediated RNAi re-
sponse. As little is known about the efficiency and/or toxicity of
transfection reagents in KC cells, a pilot experiment was carried
out with either fluorescently labeled dsRNAmolecules or plasmid
DNA and by using different transfection reagents. At 24 h post-
seeding, KC cells were incubated with fluorescein-labeled dsRNA
or fluorescein-labeled plasmid DNA in the absence or presence of
different transfection reagents (Fugene HD, GeneJammer, or
Lipofectamine 2000) by following themanufacturer’s protocol. At
24 h postincubation, we estimated the number of transfected cells
(green cells) by fluorescence microscopy, with at least 400 cells
counted for each condition (data not shown). No obvious toxicity
was detected 24 h posttransfection (data not shown). Use of Fu-
gene and GeneJammer resulted in similar numbers of transfected
cells (between 14% and 23%). Lipofectamine 2000-mediated
transfection resulted in the highest number of transfected cells for
dsRNA (approximately 40%), similarly to what we obtained in
cells incubated with dsRNA in the absence of transfection reagent
(32.5%). In contrast, transfection of KC cells using Lipofectamine
2000 gave 5% of transfected cells after plasmid DNA transfec-
tion, compared to 27% in GeneJammer and 11% in Fugene. No
TABLE 1 List of primer sequences used
Gene Upstream/downstream primer sequence (5=¡3=)a
BTV-1 NS1 GTA ATA CGA CTC ACT ATA GGG TCGGTGGG
AATGGCTTAT
GTA ATA CGA CTC ACT ATA GGG CTTTTCTG
CATAGCATAGGGTG
eGFP, 400 nt GTA ATA CGA CTC ACT ATA GGG GGCGTGC
AGTGCTTCAGCCGC/
GTA ATA CGA CTC ACT ATA GGG GTG
GTTGTCGGGCAGCAGCAC
Firefly luciferase GTA ATA CGA CTC ACT ATA GGG ATGGAAGC
AGCCAAAAAC
GTA ATA CGA CTC ACT ATA GGG TTACACG
GCGATCTTTCC
a The T7 promoter region is indicated in italics.
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green fluorescing cells were observed if plasmid DNA was added
to cells in the absence of a transfection reagent.
Next, we determined the ability of dsRNA, either added to the
medium or transfected with GeneJammer, to silence a firefly lu-
ciferase (FFluc) reporter gene. Cells were cotransfected with plas-
mids expressing FFluc as well as Renilla luciferase (RLuc) as an
internal control expressed from baculovirus promoters (OpIE2
for FFluc in pIZ-Fluc andAcIE1 forRLuc in pAcIE1-Rluc). At 24 h
postseeding, we induced an RNAi response by transfection (Fig.
1A) or addition (Fig. 1B) of different concentrations of either
eGFP-specific control dsRNA (ds-control) or dsRNA targeting
FFluc. We assessed luciferase activities 24 h after the addition of
dsRNA. A concentration-dependent reduction of luciferase activ-
ity was found for cells treated with FFluc-specific dsRNA, regard-
less of whether dsRNA was transfected (Fig. 1A) or added to the
cell culturemedium (Fig. 1B). These results show that KC cells are
able to induce a sequence-specific, dsRNA-dependent RNA si-
lencing response. In addition, our data show that, similarly to
what has been reported for Schneider-2 (S2) drosophila cells (56,
57), KC cells are able to take up dsRNA from culture medium.
The dsRNA-inducible RNAi response inmidge cells displays
antiviral activity.We next investigated the ability of this pathway
to inhibit virus replication. As BTV is known to be transmitted to
susceptible mammals via Culicoides species (27), we used this vi-
rus to investigate the dsRNA-induced antiviral RNAi response in
KC cells. We first transfected the KC cells with dsRNA targeting
BTV-1 NS1 or eGFP-specific control dsRNA. After 24 h, we in-
fected the cells with BTV-1 at a multiplicity of infection (MOI) of
0.2. The success of silencing was assessed at 24 h postinfection by
immunofluorescence (Fig. 2A) andWestern blot detection (Fig. 2C)
using an NS1-specific antibody. A reduction in NS1-positive cells
was detected when dsRNA targeting NS1 was transfected and com-
pared to control dsRNA. Approximately 35% of control dsRNA-
transfected cells expressed BTV-1 NS1 as assessed by fluorescence
microscopy, in contrast to 15% when dsRNA targeting NS1 was
transfected (Fig. 2B).We confirmed these results byWestern blot-
ting, where levels of NS1 expression were greatly reduced in cells
transfected with virus-specific dsRNA (Fig. 2C). BTV NS1 has
been shown to be important for viral replication (58, 59), and
consequently knockdown of NS1 expression will have a negative
effect on virus production.We thereforemeasuredBTV infectious
viral particles released in the supernatant of KC cells incubated
with dsRNA (targeting BTV-1 NS1 or control) at 24 h postinfec-
tion. As expected, a significant decrease in BTV-1 production was
detected in cells incubated with dsRNA targeting NS1 compared
to that of control infections (Fig. 2D). Similar results were ob-
tained when we added (rather than transfected) dsRNA to the
culture medium (data not shown), suggesting a capability for an-
tivirally active dsRNA uptake similar to that observed for Dro-
sophila cell lines (56, 57).
Culicoides cells can mount an RNAi response against the
dsRNA bluetongue virus. Having shown that RNAi can be in-
duced in KC cells following dsRNA transfection, we investigated
whether such a response could be induced following viral in-
fection. Induction of an antiviral RNAi response is character-
ized by the production of small RNAmolecules that map to the
viral genome and/or antigenome (5, 6, 11, 12, 19, 20, 60). We
isolated total RNA from KC cells 24 h postinfection with
BTV-1, and we then sequenced small RNAs below 40 nt by
Illumina Solexa sequencing and determined the sequences, fre-
quencies, and BTV genome location. For most BTV-1 seg-
ments, the viRNA molecules produced in infected KC cells
were predominantly 21 nt in length and mapped to both the
coding and noncoding strand with similar frequencies (Fig. 3
FIG 1 KC cells have a functional dsRNA-inducible RNAi pathway. KC cells
were cotransfected with plasmids pAcIE1-Rluc and pIZ-Fluc. Following trans-
fection, different concentrations of either eGFP-specific (ds-control) or FFluc-
specific (dsFFLuc) dsRNA were either transfected (A) or added to the culture
media 24 h posttransfection of plasmids (B). The relative luciferase expression
(FFluc/RLuc) was determined at 48 h posttransfection (hpt). The mean with
standard error is shown for two independent experiments performed in trip-
licate. *, P 0.05, t test.
FIG 2 BTV-1 can be targeted by dsRNA in KC cells. (A) KC cells were trans-
fected with either eGFP-specific control dsRNA or dsRNA targeting BTV NS1
(dsNS1), followed by BTV-1 infection at 24 h posttransfection. Twenty-four
hours postinfection (hpi), cells were fixed and BTV-infected cells were visual-
ized using a BTVNS1-specific primary antibody and an anti-rabbit secondary
antibody conjugated to Alexa 488 (green signal). Cell nuclei were stained with
DAPI. (B) Quantification of fluorescent cells. Infected and noninfected cells
were counted, and the respective percentages from three independent experi-
ments for each treatment were determined. (C) BTV-1 NS1 expression was
determined byWestern blot analysis in lysates of dsRNA-transfected andBTV-
1-infected KC cells at 24 h postinfection using a BTV NS1-specific primary
antibody. Western blot detection of actin was used as a loading control. (D)
BTV-1 titers in cell culture supernatant, determined 24 h postinfection.Means
from three independent experiments are shown; error bars represent standard
errors. *, P 0.05, t test.
Schnettler et al.
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and 4). The 21-nt viRNAs were distributed along the coding
and noncoding genome strand with variable frequency and a
hot (high viRNA reads) and cold (low or no viRNA reads) spot
distribution, similar to what has been described for mosquito-
borne arboviruses (5, 6, 11, 12, 19, 20, 60). The frequency of the
viRNAs was segment dependent. In addition to 21-nt viRNAs,
other classes of small RNAs between 26 to 31 nt in length with
a bias for the BTV-1 coding strand were also identified. The
frequency of these longer RNAs differed per segment from few
(segment 1) to the majority of virus-specific small RNAs (seg-
ment 9) (Fig. 3 and 4). To determine if these results were spe-
cifically induced by BTV, we investigated the produced small
RNAs against BTV-1 in the nonvector cell line Aag2 (derived
from Aedes aegypti). We established by fluorescence micros-
copy that BTV-1 was able to infect Aag2 cells at levels compa-
rable to KC cells (Fig. 5). RNA was isolated 48 h postinfection,
and small RNAs were sequenced on the Illumina sequencing
platform as described before. The viRNA production pattern,
FIG 3 BTV-1 is targeted by the RNAi response in KC cells. Size distribution of small RNAmolecules mapping to each segment (1 to 10) of BTV-1 in KC cells at
24 h postinfection. The y axis indicates the frequency of small RNAs; the x axis indicates the length in nucleotides. Dark grey indicates small RNAs mapping to
the coding strand, and light grey indicates small RNAs mapping to the noncoding strand.
Antiviral RNA Silencing in Culicoides Cells
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including the larger class of virus-specific small RNAs, was
largely conserved in Aag2 cells infected with BTV-1 (Fig. 6 and
7). Importantly, pattern, location, and frequencies of viRNA
production were conserved mainly between independent ex-
periments (data not shown). Together, these data show that the
antiviral RNAi responses following infection by BTV of C. so-
norensis-derived KC cells and Aedes aegypti-derived Aag2 cells
are broadly comparable and are predominantly characterized
by the production of 21-nt viRNAs for most of the segments.
Culicoides cells can mount an RNAi response against the
negative-strand RNA Schmallenberg virus. SBV is a recently
emerged pathogen belonging to theOrthobunyavirus genus of the
Bunyaviridae family and is thought to be most probably midge-
borne (4). We infected KC cells with SBV, and RNA was isolated
24 h postinfection to determine if a similar production pattern of
viRNA production is observed in KC cells infected with an arbo-
virus belonging to a different virus family from the Reoviridae.
Infection experiments indicated that SBV infects and replicates
FIG 4 Distribution of 21-nt viRNAs of BTV-1 in KC cells. Frequency distribution of 21-nt viRNAs to each segment (1 to 10) of BTV-1. The y axis shows the
frequency of the 21-nt viRNAs mapping to the corresponding nucleotide position on the x axis. Positive numbers and peaks represent the frequency of viRNAs
mapping to the coding strand (in 5=¡3= orientation). Negative numbers and peaks represent those viRNAs mapping to the noncoding strand (in 3=¡5=
orientation).
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with low frequency in KC cells even after high multiplicity of in-
fection (Fig. 8 A and B). Similar experiments performed on Aag2
cells showed enhanced infection and replication of SBV (Fig. 8A
and B). Therefore, SBV-infected Aag2 cells were used in order to
investigate if the results obtained for BTV-1-infectedKC andAag2
cells could be broadened to another arbovirus. Sequences, fre-
quencies, and SBV genome locations of small RNAs below 40 nt
were determined as described above. As shown in Fig. 8C, 21-nt
viRNAs are the predominant species of viRNA in KC cells and for
most of the segments in Aag2 cells. Again, a distribution along the
L, M, or S genome and antigenome with hot and cold spots was
observed (Fig. 9A). In both KC and Aag2 cells, most viRNA reads
are generated by the S segment, followed by theM and L segments
(Fig. 8C). In addition to 21-nt viRNAs, small RNAs in the size
range of 24 to 30 nt with a bias for the positive antigenome strand
were detected in Aag2-infected cells and matched with all three
viral segments, although at different frequencies. In the case of the
S segment, these larger small RNAs represented the majority of
small RNAs (Fig. 8C). As described above, similar class sizes of
small RNAs were also detected in BTV-1-infected KC and Aag2
cells. This size range of small RNAs normally represents the group
of PIWI-interacting RNA (piRNA) molecules, known to be im-
portant in suppressing transposons in germ line cells in various
organisms, including drosophila, zebrafish, and mice (61–65).
Primary piRNAs are normally antisense to the genomic regions
(mostly transposons) and target transposon-derived single-
stranded sense RNA. Upon cleavage, secondary piRNAs are pro-
duced that are mostly sense and used to find complementary an-
tisense RNA, resulting again in primary-type piRNAs. Recently,
virus-specific piRNA-like molecules have been reported for sev-
eral arboviruses, including CHIKV, Sindbis virus (SINV), and
LACV in aedine mosquitoes or their derived cell lines (6, 18, 19,
44). Due to the so-called “ping-pong” mechanism of piRNA pro-
duction, piRNAs have specific features. The primary piRNAs are
in antisense orientation and have a bias for uridine at position 1.
In contrast, secondary piRNAs are in the sense orientation and
have an adenine at position 10. In addition, complementary
piRNAs and viral piRNA-like molecules of LACV and SINV are
often separated at the 5= end by 10 nucleotides (44, 66). Most of
the SBV-specific small RNAs of 24 to 30 nt produced in Aag2 cells
have piRNA-specific features (sense [antigenome] with A10 and
antisense [genome] with U1 [Fig. 10A] and separation of comple-
mentary RNAs at the 5= end by 10 nucleotides [Fig. 10B]), in
particular those produced from the M and S segments. They are
distributed along the segments and do notmap to a specific region
of the segments (Fig. 9B). In contrast, the BTV-1-specific 24- to
31-nt small RNAs produced in KC andAag2 cells do not show any
specific sequence logo (data not shown). Pattern, location, and
frequencies of viRNA production were conservedmainly between
independent repetitions (data not shown).
Taken together, our data show that midge-derived KC cells
mount an antiviral RNAi response following infection with arbo-
viruses with different genome structures. Regardless of the virus
infecting these cells, viRNAs of 21 nt in lengthwere found to be the
dominant class of virus-specific small RNA. Thus, the Culicoides
antiviral RNAi response resemblesmainly similar pathways found
in mosquitoes. Larger small RNAs with features of piRNA-like
molecules were found for SBV-infected Aag2 cells but not KC
cells. Although similar RNA molecules were detected in BTV-in-
fected KC and Aag2 cells, these RNAs do not possess piRNA-
specific features.
DISCUSSION
RNAi (and in particular the exogenous RNAi pathway) has been
shown to be amajor antiviral response against arboviruses inmos-
quitoes and an important process regulating this virus/host inter-
action (13, 14). Culicoides midges are one of the major inverte-
brate vectors of several arboviruses of humans and livestock. In
this study, we have shown that C. sonorensis-derived KC cells
mount an antiviral RNAi response.
Drosophila cells have been reported to take up dsRNA from
culture medium, a phenomenon not observed for any of the mos-
quito-derived cell lines (56, 57). Interestingly, we show that also
KC cells are able to take up dsRNA molecules directly from the
culture medium, although the precise pathway for dsRNA uptake
is not known. Several genes have been linked with the dsRNA
uptake inD. melanogaster, suggesting receptor-based endocytosis
(56, 57, 67). Due to the lack of genomic information onCulicoides,
it is currently difficult to draw any comparisons.
dsRNA and siRNA molecules have been used to target and
silence a variety of viruses in numerous organisms. Evenmamma-
lian cells, believed to not naturally mount a siRNA-based antiviral
RNAi response upon viral infection, can induce an siRNA-based
antiviral RNA silencing response after transfection of siRNAmol-
ecules (68). Therefore, successful inhibition of virus production
following transfection of dsRNA targeting viral sequences cannot
be used solely as an indication that such an antiviral RNA silencing
response occurs during natural infection. A key feature of antiviral
RNAi in mosquitoes (as in other insects) is the production of
21-nt viRNA molecules (13, 14). Deep sequencing of KC cells
infected with two different midge-borne arboviruses (BTV and
SBV) shows that the majority of viRNAs for most BTV genomic
segments (8 out of 10) and all SBV segments are 21 nt in length.
viRNAs in mosquito cells (and other insects) are produced by
Dcr-2 cleavage of dsRNAmolecules that could derive either from
replicative intermediates or secondary structures within the viral
transcripts (14) but also the viral genome itself in case of dsRNA
viruses such as BTV. From the available viRNA profiles, replica-
tion intermediates are generally the favored Dcr-2 substrate can-
didates. This is supported by the scattering of viRNAs across the
whole genome/antigenome, the presence of hot and cold spots of
viRNA production (5, 6, 11, 12, 19, 20, 69), and no real preference
of a longer stretch of only the genome or antigenome as the pro-
ducer of 21-nt RNAs, which would be expected if secondary RNA
structures are the favored Dcr-2 substrate. Recently, it has been
FIG 5 BTV-1 infects nonvector mosquito Aag2 cells. BTV-infected KC and
Aag2 cells were fixed at 48 h postinfection, and expression of NS1 protein was
monitored by immunofluorescence (bright signal). Cell nuclei were stained
with DAPI.
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shown that certain RNAs can be over- or underrepresented in
small RNA libraries, due to low sequencing depth and cloning bias
(70, 71). Some of the observed hot and cold spots could be the
result of such a cloning bias; however, the presence of small RNAs
mapping to the noncoding strand of BTVwith a similar frequency
as to the coding strand strongly supports the dsRNA genome as
the RNAi inducer molecule. Before this study, it was not immedi-
ately apparent whether an RNAi response of 21-nt viRNAs would
be induced following infection by viruses with a dsRNA genome
like the orbivirus BTV and if the inducer molecules would be the
dsRNA genome or secondary structures in the viral transcripts.
Considering that synthesis of the negative-sense RNA during the
viral replication cycle is believed to occur only within the newly
assembled viral particles, the secondary structures of the viral
transcripts would be the favored RNAi inducer molecule; this
strategy helps dsRNA viruses also to shield them from host pro-
FIG 6 BTV-1 infection is targeted by the RNAi response in Aag2 cells. Size distribution of small RNAmolecules mapping to each segment (1 to 10) of BTV-1 in
Aag2 cells at 48 h postinfection. The y axis indicates the frequency of small RNAs; the x axis indicates the length in nucleotides. Dark grey indicates small RNAs
mapping to the coding strand, and light grey indicates small RNAs mapping to the noncoding strand.
Schnettler et al.
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teins such as RNA sensors that activate the antiviral interferon
pathway in mammals (72–76). Thus, viRNAs of dsRNA viruses
could have been solely derived from the secondary structures of
the coding RNA strand (which functions as mRNA), or these vi-
ruses could escape antiviral RNAi altogether (72, 75, 76). The
features of BTV viRNAs detected in our study (scattering across
the whole genome in sense and antisense patterns) indicate that at
least a small amount of dsRNA viral genome is accessible to the
RNAi machinery and probably not protected by the double-lay-
ered viralmembrane particles, as recently shown for the induction
of interferon (IFN) in mammalian cells by BTV dsRNA (77).
These results are in linewith the detection of viRNAs derived from
dsRNAviruses (the birnavirus drosophila X virus [DXV] aswell as
drosophila totivirus) (78) during persistent infection in a dro-
sophila cell line and the increase in susceptibility for DXV in
RNAi-deficient drosophila (79). The resulting viRNAs are ex-
pected to be able to target the BTV transcripts present in the cy-
toplasm, resulting in less viral protein production and subse-
FIG 7 Distribution of 21-nt viRNAs of BTV-1 in Aag2 cells. Frequency distribution of 21-nt viRNAs in infected Aag2 cells to each segment (1 to 10) of BTV-1.
The y axis shows the frequency of the 21-nt viRNAs mapping to the corresponding nucleotide position on the x axis. Positive numbers and peaks represent the
frequency of viRNAs mapping to the coding strand (in 5=¡3= orientation). Negative numbers and peaks represent those viRNAs mapping to the noncoding
strand (in 3=¡5= orientation).
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quently reduced virus titers, as shown in this study. In addition to
the 21-nt viRNAs, larger classes of BTV-specific small RNAs of 26
to 31 nt in length were detected. This resembles the size distribu-
tion of piRNAs, a class of Dicer-independent small RNAs found in
vertebrate and invertebrates thought mainly to be important for
genome stability in germ line cells by targeting transposons (61–
65). Recently, virus-specific piRNA-like small RNAs were found
in arbovirus-infected aedine mosquitoes and derived cell lines.
These piRNA-like molecules were found to map mainly to the
coding strand of the viral genome of positive-strand RNA arbovi-
ruses but also to the antigenomeof LACV (18, 19, 44).Due to their
production pathway (the so-called ping-pong amplification
mechanism), piRNAs and viral piRNA-like molecules have a spe-
cific sequence logo (61–65). BTV-specific small RNAs of 26 to 31
nt in length do not show a piRNA-like sequence logo (not shown).
It is not known how these larger BTV-specific RNAmolecules are
produced, or their function, or if they are related to RNAi pro-
cesses at all. Their production is virus specific and not cell type
specific, as we also detected them in the Aag2 mosquito cell line.
In the case of SBV, 21-nt viRNAs could be detected in both KC
and Aag2 cells for all three segments in an asymmetric distribu-
tion, suggesting again a dsRNA replication intermediate as the
inducer of the RNAi response. This is in line with results observed
in drosophila cells infectedwith LACV (6). Compared to infection
with positive-strand RNA viruses or dsRNA viruses, no dsRNA
could be detected for negative-strand RNA viruses, at least in in-
fected vertebrate cells (80). Our results indicate that dsRNA rep-
licative intermediates are present in orthobunyavirus-infected
cells, possibly at low levels but levels still sufficient to induce an
antiviral RNAi response. Longer small RNAmolecules containing
FIG 8 SBV infection and targeting by the RNAi response in KC and Aag2 cells. (A) Virus production in supernatant of KC (triangle) and Aag2 (square) cells
infected with SBV at a MOI of 10 was determined at various time points postinfection (0, 8, 24, and 48 h) by plaque assay. A representative of two independent
experiments performed in triplicate is shown; standard errors are indicated. (B) SBV-infected KC and Aag2 cells were fixed at 48 h postinfection, and SBV-
infected cells were visualized by using an SBVN-specific primary antibody (bright signal). Cell nuclei were stainedwithDAPI. (C) Size distribution of small RNA
molecules mapping to L,M, and S of SBV in KC cells at 24 h postinfection or in Aag2 cells at 48 h postinfection. The y axis indicates the frequency of small RNAs;
the x axis indicates the length in nucleotides. Dark grey indicates small RNAs mapping to the coding strand, and light grey indicates small RNAs mapping to the
noncoding strand.
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piRNA features were also detected in SBV-infected Aag2 cells, as
recently described for other bunyaviruses (LACV, Rift Valley fever
virus [RVFV]) in RNAi-deficient Aedes albopictus-derived C6/36
cells and other arboviruses (such as CHIKV, SINV, DENV, and
RVFV) in aedine mosquitoes and/or their derived cell lines (18,
19, 44, 81). As no piRNA-like molecules could be detected in any
of the BTV-1-infected cell lines, production of piRNA-like mole-
cules may be specific to single-stranded RNA viruses, though
more research is needed to answer this question. It is not known if
these piRNA-like molecules have an antiviral function and how
they are induced. Neither BTV nor SBV produced piRNA-like
molecules in KC cells. This could be due to either the lack of a
piRNA pathway inCulicoides species or, alternatively, a deficiency
of the KC cell line.
The detection of BTV- or SBV-specific 21-nt viRNAs indi-
cates the ability of KC cells to induce an antiviral RNAi re-
sponse. In the absence of any genomic information on Culi-
coides, we can only speculate that orthologs of exogenous RNAi
pathway proteins such as Dcr-2 or Ago-2 are present in the
midge genome. However, the presence of 21-nt viRNAs is a
strong indicator for the presence of an exogenous RNAi path-
way that is comparable to that of mosquitoes (14). This raises a
number of questions: most importantly, how is BTV or SBV
able to successfully replicate and infect its midge vectors? Plant
and true insect viruses have been reported to encode proteins
able to interfere with the antiviral RNA silencing response by
expressing RNA silencing suppressor proteins (RSS) (23, 82).
Until now, no RSS protein has been identified in arboviruses,
suggesting other strategies for inhibition or evasion of the
RNAi response. Previous data obtained from SFV infection of
mosquito cells suggests a decoy mechanism: viRNAs that are
produced at high concentrations are not able to target the virus
efficiently in contrast to viRNAs produced at low concentra-
tions that result in efficient silencing of the virus. This strategy
results in successful replication at least for some time postin-
fection, even though viRNAs are produced (12). Themosquito-
borne flaviviruses WNV and DENV have been recently shown
to express a subgenomic flavivirus RNA able to interfere with
the RNAi response in mosquito cells, thereby ensuring efficient
viral replication (83). However, all mosquito-borne arbovi-
ruses investigated thus far are efficiently targeted by the RNA
silencing response (5, 6, 11, 12, 19, 20, 60). Further research is
needed to determine if and whether SBV or BTV do have any
(even if weak) RNAi evasion/inhibition strategies.
Taken together, our findings define for the first time the pres-
ence of an RNAi response inCulicoides cells which is able to target
midge-borne arboviruses and resembles at least in part the exog-
enous antiviral RNAi pathway of mosquitoes. More work will be
FIG 9 Distribution of SBV-derived small RNAs in Aag2 cells. Frequency distribution of 21-nt viRNAs (A) or 24- to 29-nt small RNAs (B) to L, M, and S of SBV
in Aag2 cells at 48 h postinfection. The y axis shows the frequency of the 21-nt viRNAs mapping to the corresponding nucleotide position on the x axis. Positive
numbers and peaks represent the frequency of viRNAsmapping to the coding strand (in 5=¡3= orientation), and negative numbers/peaks indicate those viRNAs
mapping to the noncoding strand (in 3=¡5= orientation).
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required to determine the exact mechanisms and proteins in-
volved in the RNAi pathway in midges, but this study allows fur-
ther investigations into these processes.
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